Summary

Market Overview
The Global Kinase Screening and Profiling Services Market, valued at USD 370.12 Million in 2024, is projected to experience a CAGR of 5.55% to reach USD 511.79 Million by 2030. Kinase screening and profiling services encompass the specialized biochemical and cell-based assays used to identify, characterize, and evaluate the activity and selectivity of compounds against a broad range of kinase enzymes, which are critical drug targets across various therapeutic areas.
Key Market Drivers
The escalating prevalence of chronic diseases and the surging demand for personalized medicine, particularly within precision oncology, are pivotal factors expanding the Global Kinase Screening and Profiling Services Market. The rising incidence of chronic conditions, especially various forms of cancer, necessitates continuous efforts in drug discovery to identify novel therapeutic targets and agents. Kinases represent a crucial class of enzymes implicated in the pathophysiology of numerous chronic diseases, making their inhibition or modulation a significant focus for pharmaceutical development.
Key Market Challenges
The substantial cost associated with advanced kinase screening and profiling technologies presents a significant impediment to the growth of the Global Kinase Screening and Profiling Services Market. These high expenses directly restrict the accessibility of cutting-edge screening platforms for numerous biotechnology startups and smaller pharmaceutical companies. Such organizations frequently operate with constrained research and development budgets, making large investments in specialized, high-throughput screening services financially prohibitive. This limitation often forces them to either defer advanced screening projects or opt for less comprehensive, and therefore less effective, alternatives.
Key Market Trends
Artificial Intelligence and Machine Learning Integration is transforming kinase drug discovery by significantly enhancing the efficiency and speed of identifying and optimizing novel therapeutic compounds. These technologies allow for rapid analysis of vast datasets, prediction of kinase-ligand interactions, and more accurate filtering of potential drug candidates. According to a study published by PharmTech in October 2024, 68% of pharmaceutical experts were utilizing AI and ML in their work, a notable increase from 54% in the previous year.
Key Market Players
• MedChemExpress LLC
• Eurofins Scientific SE
• Thermo Fisher Scientific, Inc.
• Reaction Biology Corp.
• BPS Bioscience, Inc.
• Creative Biogene Inc.
• Luceome Biotechnologies L.L.C.
• Kinexus Bioinformatics Corp.
• LC Sciences LLC
• HD Biosciences Co., Ltd.
Report Scope:
In this report, the Global Kinase Screening and Profiling Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Kinase Screening and Profiling Services Market, By Type:
o Radioisotope Method
o Homogeneous Non-radioisotope Method
• Kinase Screening and Profiling Services Market, By Application:
o Enterprise
o Research Institute
• Kinase Screening and Profiling Services Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Kinase Screening and Profiling Services Market.
Available Customizations:
Global Kinase Screening and Profiling Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Kinase Screening and Profiling Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Radioisotope Method, Homogeneous Non-radioisotope Method)
5.2.2. By Application (Enterprise, Research Institute)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Kinase Screening and Profiling Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Kinase Screening and Profiling Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.2. Canada Kinase Screening and Profiling Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.3. Mexico Kinase Screening and Profiling Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
7. Europe Kinase Screening and Profiling Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Kinase Screening and Profiling Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.2. France Kinase Screening and Profiling Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.3. United Kingdom Kinase Screening and Profiling Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.4. Italy Kinase Screening and Profiling Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.5. Spain Kinase Screening and Profiling Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
8. Asia Pacific Kinase Screening and Profiling Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Kinase Screening and Profiling Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.2. India Kinase Screening and Profiling Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.3. Japan Kinase Screening and Profiling Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.4. South Korea Kinase Screening and Profiling Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.5. Australia Kinase Screening and Profiling Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
9. Middle East & Africa Kinase Screening and Profiling Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Kinase Screening and Profiling Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.2. UAE Kinase Screening and Profiling Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.3. South Africa Kinase Screening and Profiling Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
10. South America Kinase Screening and Profiling Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Kinase Screening and Profiling Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.2. Colombia Kinase Screening and Profiling Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.3. Argentina Kinase Screening and Profiling Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Kinase Screening and Profiling Services Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. MedChemExpress LLC
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Eurofins Scientific SE
15.3. Thermo Fisher Scientific, Inc.
15.4. Reaction Biology Corp.
15.5. BPS Bioscience, Inc.
15.6. Creative Biogene Inc.
15.7. Luceome Biotechnologies L.L.C.
15.8. Kinexus Bioinformatics Corp.
15.9. LC Sciences LLC
15.10. HD Biosciences Co., Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer